http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3a64f443d48ecf4a4de75e120a9c8f0
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Jirström |
| name | Karin Jirström |
| given-name | Karin |
| organization-name | 7Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. Department of Pathology Lund University and Skåne University Hospital Lund Sweden Authors' Affiliations: 1The CRUK Inositide Laboratory; 2Breakthrough Breast Cancer Research Unit; 3Leukaemia Biology, Inositide Group Cancer Research UK Manchester Institute, The University of Manchester, Manchester; 4Applied Bioinformatics of Cancer, University of Edinburgh Cancer Research UK Centre, Edinburgh, United Kingdom; and 5Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden Authors' Affiliations: UCD Schools of 1Biomolecular and Biomedical Science, 2Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield; 3Molecular Therapeutics for Cancer Ireland, National Institute for Cellular Biotechnology, Dublin City University, Glasnevin; 4St. Vincent's University Hospital, Elm Park, Dublin, Ireland; 5Queensland Centre for Gynaecological Cancer, University of Queensland, School of Medicine, Central Clinical Division, Brisbane, Australia; and 6Department of Clinical Sciences, Division of Pathology, Lund University, Skåne University Hospital, Lund, Sweden Department of Clinical Sciences Lund, Division of Oncology and Pathology Lund University Lund Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, SE 22185 Lund, Sweden; Department of Pathology, Regional Laboratories Region Skåne, SE 22185 Lund, Sweden Authors' Affiliations: 1Center for Molecular Pathology and 2CREATE Health, Department of Laboratory Medicine, University Hospital MAS, Malmö, Sweden; and 3Department of Clinical Science, Lund University, Lund, Sweden; Authors' Affiliations: 1Center for Molecular Pathology and 2CREATE Health, Department of Laboratory Medicine, University Hospital MAS, Malmö, Sweden; and 3Department of Clinical Science, Lund University, Lund, Sweden Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology Lund University Lund Sweden Department of Clinical Sciences, Pathology, Lund University, Sweden Division of Oncology and Pathology, Lund University, Lund, Sweden; Department of Genetics and Pathology, Laboratory Medicine, Lund, Sweden Department. of Clinical Sciences Division of Pathology, Lund University, Skåne University Hospital Lund Sweden Department of Clinical Sciences, Pathology, Lund University, Skåne University Hospital, Lund, Sweden Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Lund, Sweden Division of Pathology, Department of Clinical Sciences Lund University and Regional Laboratories Region Skåne Lund Sweden Department of Clinical Sciences, Pathology Lund University Skane University Hospital Lund Sweden Department of Clinical Sciences Lund Oncology and Pathology, Lund University Lund Sweden Division of Oncology and Pathology Department of Clinical Sciences Lund Lund University Skåne University Hospital Lund Sweden Authors' Affiliations: 1Department of Oncology-Pathology, Cancer Center Karolinska, Karolinska Institutet, Stockholm, Sweden; 2Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan; 3Department of Genetics and Pathology, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden; Departments of 4Cardiothoracic Surgery and 5Pathology, Lund University Hospital, Lund, Sweden; 6Department of Cell and Molecular Biology, University of Gothenburg, Lundberg Laboratory, Gothenburg, Sweden; and 7Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Malmö University Hospital, Malmö, Sweden Department of Clinical Sciences, Lund University, Lund, Sweden Department of Surgery Skane University Hospital, Lund University Malmö Sweden Authors' Affiliations: 1Department of Experimental Medical Science, 2Department of Clinical Science, Division of Oncology, and 3Department of Clinical Science, Division of Pathology, Lund University; 4Skåne Department of Oncology, Skåne University Hospital, Lund, Sweden; and 5Medical Research Division, Regional Academic Health Center, The University of Texas Health Science Center at San Antonio, Edinburg, Texas; Authors' Affiliations: 1Department of Experimental Medical Science, 2Department of Clinical Science, Division of Oncology, and 3Department of Clinical Science, Division of Pathology, Lund University; 4Skåne Department of Oncology, Skåne University Hospital, Lund, Sweden; and 5Medical Research Division, Regional Academic Health Center, The University of Texas Health Science Center at San Antonio, Edinburg, Texas Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University , Lund, Sweden Division of Pathology Department of Clinical Sciences Lund University Lund Sweden; Regional Laboratories Region Skåne Lund Sweden Oncology and Therapeutic Pathology, Department of Clinical Sciences Lund, Lund University , Sölvegatan 19, 221 84 Lund , Sweden Department of Clinical Sciences, Lund University, Sweden Department of Clinical Sciences, Division of Oncology and Pathology Lund University Lund Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund Lund University Lund Sweden Fredrik Wärnberg, Hans Garmo, Linda Adwall, and Lars Holmberg, Uppsala University, Uppsala; Stefan Emdin, Umeå University Hospital, Umeå; Veronica Hedberg, Gävle Hospital, Gävle; Kerstin Sandelin, Karolinska University Hospital, Stockholm; Anita Ringberg, Skåne University Hospital, Malmö; Anita Ringberg, Harald Anderson, and Karin Jirström, Lund University, Lund; Per Karlsson, Sahlgrenska University Hospital, Göteborg; Lars-Gunnar Arnesson, Linköping University Hospital, Linköping, Sweden; and Hans Garmo... Authors' Affiliations: 1Barts Cancer Institute, Queen Mary University of London; 2Cancer Research UK Bioinformatics and Biostatistics Service; 3Department of Pathology, Barts and the London NHS Trust, Royal London Hospital, London, United Kingdom; 4Ortho Biotech Oncology R&D Division of Centocor, Radnor, Pennsylvania; 5OrthoBio R&D Oncology, Division of Centocor BV, Leiden, the Netherlands; 6Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom; 7UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland; and 8Centre for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden Department of Clinical Sciences Lund Lund University Lund Sweden Authors' Affiliations: 1Departments of Pathology, 3Radiation Oncology, 5Medicine, and 7Surgery, and 6Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 2University College Dublin School of Biomolecular and Biomedical Science, University College Dublin Conway Institute, Belfield, and 4National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland; 8Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden; and 9Plexxikon Inc., Berkeley, California Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Skåne University Hospital, Lund, Sweden Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences Lund University Lund Sweden Department of Pathology, Regional Laboratories Region Skåne; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden ‡Department of Clinical Sciences and Pathology, Skåne University Hospital, Lund University, 22185 Lund, Sweden; Department of Pathology, Regional Laboratories Region Skåne, Lund SE 22185, Sweden; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE 22185, Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund Sweden 6Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Faculty of Medicine, Department of Clinical Sciences Lund, Oncology and Pathology Lund University Lund Sweden Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden Department of Clinical Sciences, Division of Pathology; Lund University; Lund Sweden 34Department of Clinical Sciences Lund, Oncology and Pathology, Lund University, Lund, Sweden.; 35Department of Surgery, Skåne University Hospital, Lund University, Malmö, Sweden. Department of Clinical Sciences, Oncology and Therapeutic Pathology, Lund University, Lund, Sweden Department of Clinical Sciences, Division of Clinical Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden; 1Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. 1Lund University and Skåne University Hospital, Department of Clinical Sciences, Lund, Division of Oncology and Pathology, Lund, Sweden. Division of Oncology and Pathology Department of Clinical Sciences Lund University SE‐221 85 Lund Sweden 33Department of Clinical Sciences, Division of Pathology, Lund University, Skåne University Hospital, Lund, Sweden. Department of Pathology Lund University Lund Sweden Department of Laboratory Medicine Center for Molecular Pathology, Lund University, Skåne University Hospital Lund Sweden 1Department of Surgery, 2Department of Genetics and Pathology, Rudbeck Laboratory, and 3Department of Oncology, Radiology, and Clinical Immunology, University of Uppsala, Uppsala, Sweden; 4Centre for Molecular Pathology, Department of Laboratory Medicine, Malmö University Hospital, Lund University, Malmö, Sweden; 5CREATE Health Centre for Translational Cancer Research, Lund University, Lund, Sweden; and 6Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; 1Department of Surgery, 2Department of Genetics and Pathology, Rudbeck Laboratory, and 3Department of Oncology, Radiology, and Clinical Immunology, University of Uppsala, Uppsala, Sweden; 4Centre for Molecular Pathology, Department of Laboratory Medicine, Malmö University Hospital, Lund University, Malmö, Sweden; 5CREATE Health Centre for Translational Cancer Research, Lund University, Lund, Sweden; and 6Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Malmö, Sweden. Lund University, Lund, Sweden 8Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden. Authors' Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2Grupo de Oncogenesis y Antitumorales, Institute of Biomedical Research (IIB Sant Pau) and Network Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain; 3Department of Immunology, Genetics and Pathology and 4Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala; 5Division of Surgery, Department of Clinical and Experimental Medicine, Faculty of Health Science, Linköping University, Linköping; Departments of 6Clinical Sciences and 7Clinical Genetics, Lund University, Lund, Sweden; and 8Children's Medical Research Institute and Sydney Medical School, University of Sydney, Sydney, Australia 1Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden. 1Department of Clinical Sciences Lund, Division of Oncology and Pathology, Faculty of Medicine, Lund University, Lund, Sweden. Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (Staaf, Nodin, Jirström, Vidarsdottir, Planck, Brunnström); Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, Lund, Sweden (Tran, Söderlund, Jirström, Brunnström) Department of Pathology, Lund University and Regional Laboratories Region Skåne, Lund, Sweden From the Department of Surgery, Helsingborgs Lasarett, Helsingborg; Department of Laboratory Medicine, Pathology, University Hospital, Malmö; Department of Oncology, University Hospital, Lund; Department of Oncology, University Hospital, Linköping; Department of Pathology and Cytology, Kalmar County Hospital, Kalmar; and South Swedish and Southeast Swedish Breast Cancer Groups, Sweden Division of Oncology and Therapeutic Pathology, Department of Clinical Sciences, Lund, Lund University and Skåne University Hospital, Lund, Sweden Department of Clinical Sciences; Division of Pathology; Lund University; Skåne University Hospital; Lund Sweden Department of Clinical SciencesDivision of PathologyLund UniversityLundSweden Department of Clinical Sciences Lund; Division of Oncology and Pathology, Lund University; Lund Sweden Departments of 1Oncology, Radiology, and Clinical Immunology, 2Surgical Science, and 3Genetics and Pathology, Uppsala University, Uppsala, Sweden; 4Department of General Oncology, Örebro University, Örebro, Sweden; 5Uppsala-Örebro Regional Oncologic Center, Uppsala, Sweden; 6King's College London, Medical School, Division of Cancer Studies, London, United Kingdom; 7Center for Clinical Research, Uppsala University, Västerås, Sweden; 8Department of Laboratory Medicine, Lund University, Lund, Sweden; and 9Department of Oncology, Helsinki University, Helsinki, Finland Division of Oncology and Therapeutic Pathology Department of Clinical Sciences Lund Lund Sweden From the Department of Pathology, Yale University School of Medicine, New Haven, CT; Division of Pathology, Departments of Laboratory Medicine and Oncology, Lund University, Lund; and the Institution of Clinical Sciences, Malmo University Hospital, Malmo, Sweden Department of Clinical Sciences Lund, Lund University Faculty of Medicine, Oncology and Pathology, Lund, Sweden Department of Clinical Sciences, Pathology, Lund University, Lund, Sweden Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Skåne University Hospital, Lund, Sweden Department of Clinical Pathology, Skåne University Hospital, Lund University, Lund, Sweden Department of Clinical Sciences Division of Oncology and Pathology Lund University Lund Sweden; Department of Genetics and Pathology Laboratory Medicine Region Skåne Lund Sweden Division of Oncology and Pathology, Department of Clinical Sciences Lund University Lund Sweden |
Incoming Links
Total number of triples: 344.